Price Targets: Developments for Thales, Safran, BNP...
The session on July 9th focuses on 28 analyst revisions in the French and European markets. Real estate, aerospace, banking, and automotive are among the monitored sectors.
Above Their Target:
Above their target: 4 values · Values covered: 62
Values above their target: Coca-ColaEuropacif (-5.3%) · MICHELIN (-5.0%) · NN GROUP (-3.9%) · AGEAS (-3.4%)
Largest target/price discrepancies:
CSG — target 30.75 euros — target/price discrepancy: +119.6%
CAPGEMINI — target 150.00 euros — target/price discrepancy: +65.0%
PROSUS — target 65.96 euros — target/price discrepancy: +63.3%
EXOR NV — target 109.00 euros — target/price discrepancy: +60.8%
ADYEN — target 1,300.00 euros — target/price discrepancy: +56.6%
Unibail-Rodamco-WE: Berenberg upgrades from 'hold' to 'buy' and raises the target from 113 to 120 euros. The median of targets is set at 115 euros — target/price discrepancy: +14.1%.
Meanwhile, Klepierre sees Berenberg initiate a 'buy' recommendation with a target raised from 40 to 41 euros.
Kaufman et Broad: BNP Paribas Exane starts coverage with an 'outperform' recommendation, while lowering the target from 37 to 34 euros.
At Sodexo, Oddo BHF initiates 'outperform' and raises the target from 46 to 60 euros. 5 analysts had already raised their targets in the last 10 days, the latest on July 8.
TFF Group undergoes two downward revisions: Oddo BHF reduces the target from 19 to 17 euros (recommendation 'neutral'), while Portzamparc lowers theirs from 26.30 to 23 euros ('buy' maintained).
A limited cut for Virbac: Jefferies confirms 'hold' but adjusts the target from 368 to 361 euros.
Thales: UBS maintains 'buy' but lowers the target from 390 to 330 euros; BofA Securities places the value 'under review' with a target set at 293 euros. Median at 290 euros, target/price discrepancy: +24.1%. An analyst had revised their target on July 6.
Double increase at Safran: UBS raises the target from 310 to 360 euros ('neutral'), Bernstein increases it from 350 to 410 euros ('outperform'). 2 analysts had already adjusted their targets upwards in the last 10 days, on July 6. Median consensus at 354.50 euros — target/price discrepancy: +6.6%.
